Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-related

NCT03313154 is registered in ClinicalTrials.gov with Azienda Ospedaliero Universitaria di Cagliari as lead sponsor.

NCT NCT03313154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03313154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-related
Lead sponsor
Azienda Ospedaliero Universitaria di Cagliari
Phase
Observational
Overall status
Completed
Start date
November 30, 2015
Completion date
September 30, 2018
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c, cognitive impairment, psychiatric disorders